drugset / Trial / NCT04892420

Comparison Between Adjuvants Added to Bupivacaine in Adductor Canal Block

NCT04892420

Phase 2 Completed 120 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Adult patients undergoing anterior cruciate ligament repair under Spinal Anaesthesia will be randomly assigned into one of the following groups (The Four study groups will receive the standard treatment in the form of spinal anesthesia and adductor canal block), using computer generated codes and opaque sealed envelopes: 1. Group DX(DEXAMETHASONE): The patients receive 20ml plain bupivacaine (0.5%) + 8 mg dexamethasone (2ml) in adductor canal block after spinal anaetthesia. 2. Group DM (dexmedetomidine)The patients receive 20 ml plain bupivacaine(0.5)+25 microgram dexmedetomidine( diluted in 2 ml normal saline) in adductor canal block after spinal anaetthesia. 3. Group M (magnesium sulphate):The patients receive 20 ml plain bupivacaine(0.5)+200 milligram magnesium sulphate (2 ml of magnesium 10%) in adductor canal block after spinal anaetthesia. 4. Group C(CONTROL): The patients receive 20ml plain bupivacaine (0.5%) + 2 ml of Normal saline in adductor canal block after spinal anaetthesia.

Timeline

Start
2021-06-09
Primary completion
2021-08-20
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 8 mg Other
Comparator Dexmedetomidine Other / unclassified 25 ug Other
Comparator Magnesium Sulfate Other / unclassified 200 mg Other
Comparator Bupivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.